Novel OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) C-terminal pentapeptide grafted poly(d,l-lactic acid) improves the proliferation and differentiation of osteoblasts: The potential bone regenerative biomaterial
-
Add time:09/04/2019 Source:sciencedirect.com
Poly(d,l-lactic acid) (PDLLA) is widely used for bone regenerative engineering, because of its proven biocompatibility and biodegradability. However, the major limitation of PDLLA is its cell recognition and low hydrophilicity. The objective of this study was to develop a novel bioactive poly(d,l-lactic acid) tethered with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) (OGP), which has been confirmed as one of the important growth factors related to bone repair/regeneration. The biomimetic material modification methods were utilized that maleic anhydride-modified poly(d,l-lactic acid) (MPLA) as raw material, the active C-terminal pentapeptide OGP(10–14) were covalently grafted onto the side chain of MPLA through amide reaction using 1‑ethyl‑3‑(3‑dimethyl aminopropyl) carbodiimide hydrochloride (EDC) and N‑hydroxysuccinimide (NHS) as the condensing agent to produce a new biopolymer (OGP(10–14)-MPLA). The OGP(10–14)-MPLA were further characterized with the Fourier transform infrared spectrometry, amino acid analyzer, elementary analysis, X-ray photoelectron spectroscopy. The results revealed that OGP(10–14) was successfully modified MPLA and its coupling efficiency was 12.40%. The data from both contact angle and water absorption showed the better hydrophilicity of OGP(10–14)-MPLA, compared with MPLA. Also, we found that OGP(10–14)-MPLA could improve the proliferation, differentiation, and mineralization of osteoblasts, indicating that the novel OGP(10–14)-MPLA has the better biocompatibility and is more osteoinductive. In conclusion, the OGP(10–14) modified MPLA have the potential for bone regenerative engineering.
We also recommend Trading Suppliers and Manufacturers of OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3). Pls Click Website Link as below: cas 132996-61-3 suppliers
Prev:Fibroin/peptide co-functionalized calcium titanate nanorods improve osteoinductivity of titanium via mimicking osteogenic niche
Next:Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) carriers) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Peptide TQS169 prevents osteoporosis in rats by enhancing osteogenic differentiation and calcium absorption09/07/2019
- Resorbable, amino acid-based poly(ester urea)s crosslinked with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) with enhanced mechanical properties and bioactivity09/06/2019
- Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) carriers09/05/2019
- Fibroin/peptide co-functionalized calcium titanate nanorods improve osteoinductivity of titanium via mimicking osteogenic niche09/03/2019
- Characterization and in vitro biological evaluation of mineral/OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) nanocomposites synthesized biomimetically on titanium09/02/2019
- OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) promotes osteogenic differentiation of mesenchymal stem cells mediated by LncRNA AK141205-induced upregulation of CXCL1309/01/2019
- Nanocellulose-collagen-apatite composite associated with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) for bone regeneration08/31/2019
- Surface modification of TiO2 nanotubes with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) to enhance osteoblast differentiation08/30/2019
- Three-dimensional printing and in vitro evaluation of poly(3-hydroxybutyrate) scaffolds functionalized with OSTEOGENIC GROWTH PEPTIDE (cas 132996-61-3) for tissue engineering08/29/2019


